13.50
price down icon0.77%   -0.12
 
loading
Schlusskurs vom Vortag:
$13.62
Offen:
$13.47
24-Stunden-Volumen:
1.60M
Relative Volume:
0.42
Marktkapitalisierung:
$1.50B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-6.6832
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
+8.55%
1M Leistung:
+24.10%
6M Leistung:
-8.74%
1J Leistung:
-28.76%
1-Tages-Spanne:
Value
$13.26
$13.88
1-Wochen-Bereich:
Value
$11.45
$14.03
52-Wochen-Spanne:
Value
$6.78
$24.76

10 X Genomics Inc Stock (TXG) Company Profile

Name
Firmenname
10 X Genomics Inc
Name
Telefon
(925) 401-7300
Name
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Mitarbeiter
1,306
Name
Twitter
@10xgenomics
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
TXG's Discussions on Twitter

Vergleichen Sie TXG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
TXG
10 X Genomics Inc
13.51 1.60B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
290.73 46.61B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
63.34 10.57B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
60.56 11.13B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
95.23 8.42B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
37.23 6.33B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-13 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-03 Eingeleitet Leerink Partners Outperform
2024-07-22 Hochstufung Jefferies Hold → Buy
2024-07-18 Herabstufung JP Morgan Overweight → Neutral
2024-07-10 Herabstufung Deutsche Bank Buy → Hold
2024-06-27 Herabstufung Wolfe Research Outperform → Peer Perform
2024-06-25 Herabstufung Guggenheim Buy → Neutral
2024-06-03 Fortgesetzt Jefferies Hold
2024-05-01 Herabstufung TD Cowen Buy → Hold
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-12-12 Hochstufung BofA Securities Underperform → Neutral
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-10 Eingeleitet Barclays Overweight
2023-03-31 Eingeleitet Stephens Overweight
2023-02-02 Eingeleitet UBS Neutral
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-08-18 Herabstufung Goldman Neutral → Sell
2022-07-25 Eingeleitet Canaccord Genuity Buy
2022-07-15 Herabstufung BofA Securities Neutral → Underperform
2022-07-15 Herabstufung William Blair Outperform → Mkt Perform
2021-10-15 Fortgesetzt Cowen Outperform
2021-09-14 Herabstufung BofA Securities Buy → Neutral
2021-03-15 Eingeleitet William Blair Outperform
2020-12-02 Eingeleitet Goldman Neutral
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-07-10 Eingeleitet Stifel Buy
2020-03-05 Eingeleitet Guggenheim Buy
2020-01-07 Eingeleitet Citigroup Buy
2019-10-07 Eingeleitet BofA/Merrill Buy
2019-10-07 Eingeleitet Cowen Outperform
2019-10-07 Eingeleitet JP Morgan Overweight
2019-09-24 Eingeleitet Evercore ISI Outperform
Alle ansehen

10 X Genomics Inc Aktie (TXG) Neueste Nachrichten

pulisher
Jul 23, 2025

What analysts say about 10x Genomics Inc. stockOutperformance with explosive growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance

Jul 23, 2025
pulisher
Jul 22, 2025

Is 10x Genomics Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

10x Genomics Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives 10x Genomics Inc. stock priceBreakout profit opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study - Agency for Science, Technology and Research

Jul 18, 2025
pulisher
Jul 18, 2025

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

10x Genomics Ends UPC Patent Fight With Bruker - Law360

Jul 17, 2025
pulisher
Jul 17, 2025

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery - the-scientist.com

Jul 17, 2025
pulisher
Jul 14, 2025

Why 10x Genomics Inc. stock attracts strong analyst attentionFree Market Sentiment Analysis - beatles.ru

Jul 14, 2025
pulisher
Jul 11, 2025

Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - Yahoo Finance

Jul 11, 2025
pulisher
Jul 11, 2025

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 - BioSpace

Jul 11, 2025
pulisher
Jul 03, 2025

10x Genomics Reaches Analyst Target Price - Nasdaq

Jul 03, 2025
pulisher
Jul 02, 2025

10x Genomics(TXG) Soars 7.88% on Strong Q1 Earnings - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

10x Genomics Insiders Sold US$768k Of Shares Suggesting Hesitancy - 富途牛牛

Jul 01, 2025
pulisher
Jun 30, 2025

10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 1000 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 1000 Dynamic Index - MarketScreener

Jun 29, 2025
pulisher
Jun 27, 2025

10x Genomics (TXG) Receives a Hold from Bank of America Securities - The Globe and Mail

Jun 27, 2025
pulisher
Jun 26, 2025

10x Genomics (TXG) Analyst Maintains Rating but Raises Price Target | TXG Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 23, 2025

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) - Yahoo Finance

Jun 23, 2025
pulisher
Jun 22, 2025

11 Best Genomics Stocks to Buy According to Hedge Funds - Insider Monkey

Jun 22, 2025
pulisher
Jun 20, 2025

Revenues Not Telling The Story For 10x Genomics, Inc. (NASDAQ:TXG) After Shares Rise 31% - simplywall.st

Jun 20, 2025
pulisher
Jun 18, 2025

10x Genomics Inc (TXG) Trading 4.12% Higher on Jun 18 - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

UPC Backs Sales Ban On Kits Infringing 10x Genomics Patent - Law360

Jun 17, 2025
pulisher
Jun 16, 2025

Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 10, 2025

Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - Insider Monkey

Jun 10, 2025
pulisher
Jun 10, 2025

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating A 28% Potential Upside For Investors - DirectorsTalk Interviews

Jun 10, 2025
pulisher
Jun 04, 2025

Forecasting The Future: 7 Analyst Projections For 10x Genomics - Benzinga

Jun 04, 2025
pulisher
Jun 04, 2025

Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Increased by Deutsche Bank AG - Defense World

Jun 04, 2025

Finanzdaten der 10 X Genomics Inc-Aktie (TXG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

10 X Genomics Inc-Aktie (TXG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Hindson Benjamin J.
See Remarks
May 22 '25
Sale
8.30
7,485
62,120
448,374
Taich Adam
Chief Financial Officer
May 22 '25
Sale
8.30
4,044
33,562
331,588
$21.18
price down icon 1.01%
$11.04
price up icon 2.09%
$19.93
price down icon 1.87%
$45.73
price down icon 2.82%
$20.89
price down icon 1.95%
health_information_services WAY
$37.47
price up icon 1.29%
Kapitalisierung:     |  Volumen (24h):